Search for a doctor

Steve R. Ommen, M.D.

  1. Cardiologist
Request an Appointment

Publications

  1. Alsidawi S, Roehl KM, Farina JM, Arsanjani R, Giudicessi JR, Geske JB, Newman DB, Ackerman MJ, Ommen SR. The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile. Am Heart J. 2024 Nov; 277:138-141 Epub 2024 July 30
    View PubMed
  2. Garmany R, Dasari S, Bos JM, Kim ET, Gluscevic M, Martinez KA, Tester DJ, Dos Remedios C, Maleszewski JJ, Dearani JA, Ommen SR, Geske JB, Giudicessi JR, Ackerman MJ. A multi-omics atlas of sex-specific differences in obstructive hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2024 Nov; 196:26-34 Epub 2024 Sept 08
    View PubMed
  3. Suppah M, Abdalla H, Roehl K, Farina J, Arsanjani R, Geske J, Ommen S, Alsidawi S. Sustained Benefits of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: Long-Term Assessment Using Artificial Intelligence-Electrocardiogram and Echocardiographic Data. J Am Soc Echocardiogr. 2024 Oct 9 Epub 2024 Oct 09
    View PubMed
  4. Sawma T, Schaff HV, Juarez-Casso F, Rahme S, Todd A, Dearani JA, Bagameri G, Ommen SR, Geske JB. Clinical features and postoperative outcomes in elderly patients undergoing septal myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Oct 9 Epub 2024 Oct 09
    View PubMed
  5. Castrichini M, Alsidawi S, Geske JB, Newman DB, Arruda-Olson AM, Bos JM, Ommen SR, Siontis KC, Ackerman MJ, Giudicessi JR. Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten. Heart Rhythm. 2024 Oct; 21 (10):2065-2067 Epub 2024 Apr 15
    View PubMed
  6. Siontis KC, Ommen SR, Maron MS, Maron BJ. Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy. Heart Rhythm 2024 Oct; 21 (10):1838-1842 Epub 2024 June 21
    View PubMed
  7. Juarez-Casso FM, Schaff HV, Patlolla SH, Todd A, Dearani JA, Geske JB, Ommen SR, Nishimura RA. Aortic valve regurgitation following transaortic septal myectomy for obstructive hypertrophic cardiomyopathy: Incidence and influence on late outcomes. J Thorac Cardiovasc Surg. 2024 Aug; 168 (2):510-518 Epub 2023 May 08
    View PubMed
  8. Sawma T, Schaff HV, Geske JB, Dearani JA, Ommen SR. Tricuspid valve surgery following septal myectomy in patients with a cardiac implantable electronic device. JTCVS Open. 2024 Aug; 20:29-36 Epub 2024 June 27
    View PubMed
  9. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Outcomes of concomitant myectomy and left ventricular apical aneurysm repair in patients with hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jul; 168 (1):96-103.e1 Epub 2023 Mar 15
    View PubMed
  10. Ergi DG, Schaff HV, Ommen SR, Lahr BD, Lee A, Karadhza A, Geske JB. Changes in left ventricular-aortic angulation are associated with the development of obstruction in hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jun 29 Epub 2024 June 29
    View PubMed
  11. Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, Dearani JA, Epps KC, Evanovich L, Ferrari VA, Joglar JA, Khan SS, Kim JJ, Kittleson MM, Krittanawong C, Martinez MW, Mital S, Naidu SS, Saberi S, Semsarian C, Times S, Waldman CB. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines. Circulation. 2024 Jun 4; 149 (23):e1239-311
  12. Burczak DR, Scott CG, Julakanti RR, Kara Balla A, Swain WH, Ismail K, Geske JB, Killu AM, Deshmukh AJ, MacIntyre CJ, Ommen SR, Nkomo VT, Gersh BJ, Noseworthy PA, Siontis KC. Persistence of left atrial thrombus in patients with hypertrophic cardiomyopathy and atrial fibrillation. J Interv Card Electrophysiol. 2024 Jun; 67 (4):731-738 Epub 2023 Sept 16
    View PubMed
  13. Qamar Y, Schaff HV, Castro-Varela A, Cui H, Dearani JA, Geske JB, Eleid MF, Lee AT, Lahr B, Ommen SR. Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy. J Thorac Cardiovasc Surg. 2024 May 14 [Epub ahead of print]
    View PubMed
  14. Ahmed EA, Schaff HV, Al-Lami HS, Lahr BD, Dearani JA, Nishimura RA, Ommen SR, Geske JB. Prevalence and influence of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy. J Thorac Cardiovasc Surg. 2024 May; 167 (5):1746-1754.e7 Epub 2022 Sept 07
    View PubMed
  15. Roehl K, Suppah M, Geske J, Newman D, Giudicessi J, Ackerman M, Ommen S, Alsidawi S. Effect of Mavacamten on Hypertrophic Cardiomyopathy Patients With Left Ventricular Outflow Tract Obstruction Provoked Only Postexercise or With Amyl Nitrite. J Am Soc Echocardiogr. 2024 May; 37 (5):566-568 Epub 2024 Jan 23
    View PubMed
  16. Karim S, Chahal CAA, Sherif AA, Khanji MY, Scott CG, Chamberlain AM, Geske JB, Ommen SR, Gersh BJ, Somers VK, Brady PA, Lin G. Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota. Mayo Clin Proc. 2024 Mar; 99 (3):362-374 Epub 2024 Feb 06
    View PubMed
  17. Brignole M, Cecchi F, Anastasakis A, Crotti L, Deharo JC, Elliott PM, Fedorowski A, Kaski JP, Limongelli G, Maron MS, Olivotto I, Ommen SR, Parati G, Shen W, Ungar A, Wilde A. Corrigendum to 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' [International Journal of Cardiology, 2023, 41:180-186]. Int J Cardiol. 2024 Feb 15; 397:131589 Epub 2023 Nov 24
    View PubMed
  18. Cui H, Schaff HV, Olson TP, Geske JB, Dearani JA, Nishimura RA, Sun D, Ommen SR. Cardiopulmonary exercise test in patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Feb; 167 (2):701-710.e3 Epub 2022 May 28
    View PubMed
  19. Giudicessi JR, Alsidawi S, Geske JB, Newman DB, Arruda-Olson AM, Bos JM, Ommen SR, Ackerman MJ. Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2024 Feb; 99 (2):341-343
    View PubMed
  20. Sun D, Schaff HV, Lentz Carvalho J, Nishimura RA, Dearani JA, Ommen SR, Blackshear JL, Geske JB. Improvement in gastrointestinal bleeding after septal myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2024 Jan; 167 (1):157-163 Epub 2022 Apr 20
    View PubMed
  21. Nguyen A, Schaff HV, Calderon-Rojas R, Qrareya MN, Ommen SR, Dearani JA, Todd A, Nishimura RA, Geske JB. Improvement in Sexual Dysfunction in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy: A Prospective Study. JACC Adv. 2024 Jan; 3 (1):100763 Epub 2023 Dec 13
    View PubMed
  22. Garmany R, Bos JM, Dasari S, Johnson KL, Tester DJ, Giudicessi JR, Dos Remedios C, Maleszewski JJ, Ommen SR, Dearani JA, Ackerman MJ. Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy. Sci Rep. 2023 Sep 1; 13 (1):14341 Epub 2023 Sept 01
    View PubMed
  23. Siontis KC, Ommen SR, Geske JB. Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions. Prog Cardiovasc Dis. 2023 Sep-Oct; 80:25-31 Epub 2023 Aug 14
    View PubMed
  24. Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Newman DB, Ommen SR. Preoperative left ventricular longitudinal strain predicts outcome of septal myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2023 Aug; 166 (2):492-500.e2 Epub 2021 Oct 06
    View PubMed
  25. Bois JP, Ayoub C, Geske JB, Wong YW, Abbasi MA, Foley TA, Mulvagh SL, Scott CG, Ommen SR, Pellikka PA. Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clin Proc Innov Qual Outcomes. 2023 Aug; 7(4):309-319. Epub 2023 Jul 19.
    View PubMed
  26. Burczak DR, Julakanti RR, Kara Balla A, Scott CG, Geske JB, Ommen SR, Nkomo VT, Gersh BJ, Noseworthy PA, Siontis KC. Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. J Am Coll Cardiol 2023 Jul 18; 82 (3):278-279
    View PubMed
  27. Garmany R, Bos JM, Ommen SR, Ackerman MJ, Geske JB. Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care. ESC Heart Fail. 2023 Jun; 10 (3):1919-1927 Epub 2023 Mar 28
    View PubMed
  28. Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L, Tome Esteban MT, Ho CY, Abraham R, Balaji S, Barth C, Berul CI, Bos M, Cannom D, Choudhury L, Concannon M, Cooper R, Czosek RJ, Dubin AM, Dziura J, Eidem B, Emery MS, Estes NAM, Etheridge SP, Geske JB, Gray B, Hall K, Harmon KG, James CA, Lal AK, Law IH, Li F, Link MS, McKenna WJ, Molossi S, Olshansky B, Ommen SR, Saarel EV, Saberi S, Simone L, Tomaselli G, Ware JS, Zipes DP, Day SM, LIVE Consortium. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2023 Jun 1; 8 (6):595-605
    View PubMed
  29. Garmany R, Bos JM, Tester DJ, Giudicessi JR, Dos Remedios CG, Dasari S, Nagaraj NK, Nair AA, Johnson KL, Ryan ZC, Maleszewski JJ, Ommen SR, Dearani JA, Ackerman MJ. Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy. Circ Genom Precis Med. 2023 Apr; 16(2):e003756. Epub 2023 Feb 20.
    View PubMed
  30. Burczak DR, Newman DB, Jaffe AS, Ackerman MJ, Ommen SR, Geske JB. High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. Mayo Clin Proc. 2023 Mar; 98 (3):410-418
    View PubMed
  31. Newman DB, Garmany R, Contreras AM, Bos JM, Johnson JN, Geske JB, Allison TG, Ommen SR, Ackerman MJ. Cardiopulmonary Exercise Testing in Athletes With Hypertrophic Cardiomyopathy. Am J Cardiol. 2023 Feb 15; 189:49-55 Epub 2022 Dec 09
    View PubMed
  32. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy. Mayo Clin Proc Innov Qual Outcomes. 2023 Feb; 7 (1):45-50 Epub 2022 Dec 30
    View PubMed
  33. Patlolla SH, Schaff HV, Nishimura RA, Eleid MF, Geske JB, Ommen SR. Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2023 Jan 3; 12 (1):e026661 Epub 2022 Dec 24
    View PubMed
  34. Lentz Carvalho J, Schaff HV, Nishimura RA, Ommen SR, Geske JB, Lahr BD, Newman DB, Dearani JA. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2023 Jan; 165 (1):79-87.e1 Epub 2021 Jan 21
    View PubMed
  35. Brignole M, Cecchi F, Anastasakis A, Crotti L, Deharo JC, Elliott PM, Fedorowski A, Kaski JP, Limongelli G, Maron MS, Olivotto I, Ommen SR, Parati G, Shen W, Ungar A, Wilde A. Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management. Int J Cardiol. 2023 Jan 1; 370:330-337 Epub 2022 Oct 26
    View PubMed
  36. Cui H, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Ommen SR. Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy. J Thorac Cardiovasc Surg. 2022 Dec; 164 (6):1863-1869.e1 Epub 2020 Dec 10
    View PubMed
  37. Burczak D, Newman DB, Jaffe AS, Ackerman MJ, Ommen SR, Geske JB. High Sensitivity Troponin T Elevation in Hypertrophic Cardiomyopathy is Associated with Ventricular Arrhythmias. Mayo Clinic Proceedings In Press. 2022.
  38. Maanja M, Noseworthy PA, Geske JB, Ackerman MJ, Arruda-Olson AM, Ommen SR, Attia ZI, Friedman PA, Siontis KC. Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice. Cardiovasc Digit Health J. 2022 Dec; 3(6):289-296. Epub 2022 Oct 22.
  39. Cui H, Schaff HV, Geske JB, Lahr BD, Dearani JA, Nishimura RA, Ommen SR. Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2022 Nov; 164 (5):1502-1509.e5 Epub 2020 Oct 28
    View PubMed
  40. Patlolla SH, Schaff HV, Nishimura RA, Geske JB, Lahr BD, Lee AT, Eleid MF, Ommen SR, Dearani JA. Mitral Annular Calcification in Obstructive Hypertrophic Cardiomyopathy: Prevalence and Outcomes. Ann Thorac Surg. 2022 Nov; 114 (5):1679-1687 Epub 2021 Nov 22
    View PubMed
  41. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ducharme MT, Ommen SR. Posterior Wall Thickness Associates With Survival Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. 2022 Nov; 10 (11):831-837 Epub 2022 Sept 07
    View PubMed
  42. Dewaswala N, Chen D, Bhopalwala H, Kaggal VC, Murphy SP, Bos JM, Geske JB, Gersh BJ, Ommen SR, Araoz PA, Ackerman MJ, Arruda-Olson AM. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports. BMC Med Inform Decis Mak. 2022 Oct 18; 22 (1):272
    View PubMed
  43. Maron BJ, Dearani JA, Smedira NG, Schaff HV, Wang S, Rastegar H, Ralph-Edwards A, Ferrazzi P, Swistel D, Shemin RJ, Quintana E, Bannon PG, Shekar PS, Desai M, Roberts WC, Lever HM, Adler A, Rakowski H, Spirito P, Nishimura RA, Ommen SR, Sherrid MV, Rowin EJ, Maron MS. Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel. Am J Cardiol. 2022 Oct 1; 180:124-139 Epub 2022 Aug 12
    View PubMed
  44. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Transapical Ventricular Remodeling for Hypertrophic Cardiomyopathy With Systolic Cavity Obliteration. Ann Thorac Surg. 2022 Oct; 114 (4):1284-1289 Epub 2022 Mar 23
    View PubMed
  45. Sun D, Schaff HV, Somers VK, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. CJC Open. 2022 Oct; 4 (10):848-853 Epub 2022 July 11
    View PubMed
  46. Calderon-Rojas R, Nguyen A, Nishimura RA, Geske JB, Ommen SR, King KS, Lee AT, Dearani JA, Schaff HV. Is there referral bias in outcomes of septal myectomy for hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2022 Sep; 164 (3):881-891 Epub 2020 Oct 09
    View PubMed
  47. Oberoi M, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Surgical Management of Hypertrophic Cardiomyopathy Complicated by Infective Endocarditis. Ann Thorac Surg. 2022 Sep; 114 (3):744-749 Epub 2022 Feb 01
    View PubMed
  48. Demaerschalk BM, Pines A, Butterfield R, Haglin JM, Haddad TC, Yiannias J, Colby CE, TerKonda SP, Ommen SR, Bushman MS, Lokken TG, Blegen RN, Hoff MD, Coffey JD, Anthony GS, Zhang N, Diagnostic Accuracy of Telemedicine Utilized at Mayo Clinic Alix School of Medicine Study Group Investigators. Assessment of Clinician Diagnostic Concordance With Video Telemedicine in the Integrated Multispecialty Practice at Mayo Clinic During the Beginning of COVID-19 Pandemic From March to June 2020. JAMA Netw Open. 2022 Sep 01; 5(9):e2229958.
    View PubMed
  49. Sun D, Schaff HV, Van Houten HK, Nguyen A, Sangaralingham LR, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Longitudinal Cost of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2022 Sep; 97 (9):1656-1663
    View PubMed
  50. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Newman DB, Ommen SR. Patient-Reported Atrial Fibrillation After Septal Myectomy for Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2022 Jun; 113 (6):1918-1924 Epub 2021 Oct 14
    View PubMed
  51. Wen S, Pislaru C, Ommen SR, Ackerman MJ, Pislaru SV, Geske JB. Right Ventricular Enlargement and Dysfunction Are Associated With Increased All-Cause Mortality in Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2022 Jun; 97 (6):1123-1133 Epub 2022 Apr 27
    View PubMed
  52. Ahmed EA, Schaff HV, Geske JB, Lee AT, King KS, Dearani JA, Nishimura RA, Ommen SR. Optimal Management of Mitral Regurgitation Due to Ruptured Mitral Chordae Tendineae in Patients With Hypertrophic Cardiomyopathy. Semin Thorac Cardiovasc Surg. 2022 May 20 [Epub ahead of print]
    View PubMed
  53. Cui H, Schaff HV, Wang S, Lahr BD, Rowin EJ, Rastegar H, Hu S, Eleid MF, Dearani JA, Kimmelstiel C, Maron BJ, Nishimura RA, Ommen SR, Maron MS. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2022 May 3; 79 (17):1647-1655
    View PubMed
  54. Sun D, Schaff HV, McKenzie TJ, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Safety of Bariatric Surgery in Obese Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 Mar 15; 167:93-97. Epub 2022 Jan 03.
  55. Patlolla SH, Schaff HV, Nishimura RA, Geske JB, Dunlay SM, Ommen SR. Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization. Mayo Clin Proc. 2022 Mar; 97 (3):507-518 Epub 2021 Dec 07
    View PubMed
  56. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Impact of Body Mass Index on Outcome of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2022 Feb; 113 (2):519-526 Epub 2021 Mar 25
    View PubMed
  57. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy. JTCVS Tech. 2022 Feb; 11:21-26 Epub 2021 Nov 01
    View PubMed
  58. Lentz Carvalho J, Schaff HV, Morris CS, Nishimura RA, Ommen SR, Maleszewski JJ, Dearani JA. Anomalous papillary muscles-Implications in the surgical treatment of hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg. 2022 Jan; 163 (1):83-89.e1 Epub 2020 Apr 15
    View PubMed
  59. Lee HJ, Kim HK, Lee SC, Ommen SR, Kim J, Park JB, Choi YJ, Lee SP, Chang SA, Kim YJ. Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy. PLoS One. 2022; 17 (2):e0264580 Epub 2022 Feb 25
    View PubMed
  60. Coffey JD, Christopherson LA, Williams RD, Gathje SR, Bell SJ, Pahl DF, Manka L, Blegen RN, Maniaci MJ, Ommen SR, Haddad TC. Development and implementation of a nurse-based remote patient monitoring program for ambulatory disease management. Front Digit Health. 2022; 4:1052408 Epub 2022 Dec 14
    View PubMed
  61. Ommen SR, Semsarian C. Hypertrophic cardiomyopathy: a practical approach to guideline directed management. Lancet. 2021 Dec 4; 398 (10316):2102-2108 Epub 2021 Sept 30
    View PubMed
  62. Siontis KC, Bhopalwala H, Dewaswala N, Scott CG, Noseworthy PA, Geske JB, Ommen SR, Nishimura RA, Ackerman MJ, Friedman PA, Arruda-Olson AM. Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up. Cardiovasc Digit Health J. 2021 Oct; 2 (5):264-269 Epub 2021 May 20
    View PubMed
  63. Cui H, Schaff HV, Somers VK, Nishimura RA, Dearani JA, Geske JB, King KS, Ommen SR. Sleep Disordered Breathing and Mortality in Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myectomy. Mayo Clin Proc. 2021 Sep; 96 (9):2323-2331 Epub 2021 July 03
    View PubMed
  64. Kwon S, Lee HJ, Han KD, Kim DH, Lee SP, Hwang IC, Yoon Y, Park JB, Lee H, Kwak S, Yang S, Cho GY, Kim YJ, Kim HK, Ommen SR. Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better. Br J Sports Med. 2021 Sep; 55 (18):1034-1040 Epub 2020 Sept 23
    View PubMed
  65. Nguyen A, Schaff HV, Ommen SR, Gersh BJ, Dearani JA, Geske JB, Lahr BD, Nishimura RA. Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2021 Jun; 111 (6):1867-1875 Epub 2020 Oct 27
    View PubMed
  66. Cui H, Schaff HV, Lentz Carvalho J, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Lee AT, Bos JM, Ackerman MJ, Ommen SR, Maleszewski JJ. Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 May 4; 77 (17):2159-2170
    View PubMed
  67. Maron MS, Ommen SR. Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy: Mavacamten in Perspective. Circulation. 2021 Mar 23; 143 (12):1181-1183 Epub 2021 Mar 22
    View PubMed
  68. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 Mar; 96 (3):601-618 Epub 2020 Dec 26
    View PubMed
  69. Sun D, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Ommen SR. Transapical Septal Myectomy for Hypertrophic Cardiomyopathy With Midventricular Obstruction. Ann Thorac Surg. 2021 Mar; 111 (3):836-844 Epub 2020 Aug 06
    View PubMed
  70. Cui H, Schaff HV, Dearani JA, Lahr BD, Viehman JK, Geske JB, Nishimura RA, Ommen SR. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2021 Mar; 161 (3):997-1006.e3 Epub 2020 Aug 25
    View PubMed
  71. Bhopalwala H, Dewaswala N, Liu S, Scott CG, Welper JM, Akinnusotu O, Bos JM, Ommen SR, Ackerman MJ, Pellikka PA, Geske JB, Noseworthy P, Arruda-Olson AM. Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy. Echocardiography. 2021 Feb; 38 (2):183-188 Epub 2020 Dec 16
    View PubMed
  72. Konecny T, Khoo M, Covassin N, Edelhofer P, Bukartyk J, Park JY, Venkataraman S, Karim S, Chahal A, Kara T, Orban M, Ludka O, Kautzner J, Ommen SR, Somers VK. Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy. Int J Cardiol. 2021 Jan 15; 323:155-160 Epub 2020 Aug 13
    View PubMed
  73. Haddad TC, Blegen RN, Prigge JE, Cox DL, Anthony GS, Leak MA, Channer DD, Underwood PY, Williams RD, Hofschulte RD, Christopherson LA, Coffey JD, TerKonda SP, Yiannias JA, Costello BA, Russi CS, Colby CE, Ommen SR, Demaerschalk BM. A Scalable Framework for Telehealth: The Mayo Clinic Center for Connected Care Response to the COVID-19 Pandemic. Telemed Rep. 2021; 2 (1):78-87 Epub 2021 Feb 24
    View PubMed
  74. Demaerschalk BM, Blegen RN, Ommen SR. Scalability of Telemedicine Services in a Large Integrated Multispecialty Health Care System During COVID-19. Telemed J E Health. 2021 Jan; 27 (1):96-98 Epub 2020 Aug 12
    View PubMed
  75. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 Dec 22; 76 (25):e159-e240 Epub 2020 Nov 20
    View PubMed
  76. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 Dec 22; 76 (25):3022-3055 Epub 2020 Nov 20
    View PubMed
  77. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P, Writing Committee Members. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22; 142 (25):e533-e557 Epub 2020 Nov 20
    View PubMed
  78. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P, Writing Committee Members. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22; 142 (25):e558-e631 Epub 2020 Nov 20
    View PubMed
  79. Mathew J, Nguyen A, Nishimura RA, Geske JB, Dearani JA, Ommen SR, Lahr BD, Schaff HV. Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease. Int J Cardiol. 2020 Nov 15; 319:97-100 Epub 2020 June 20
    View PubMed
  80. Park JB, Kim DH, Lee H, Hwang IC, Yoon YE, Park HE, Choi SY, Kim YJ, Cho GY, Han K, Ommen SR, Kim HK. Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2020 Nov; 27 (17):1849-1857 Epub 2019 Dec 01
    View PubMed
  81. Lee HJ, Kim HK, Kim M, Moon I, Lee H, Kim BS, Han KD, Park JB, Hwang IC, Yoon YE, Kim YJ, Cho GY, Ommen SR. Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients. Ann Transl Med. 2020 Nov; 8 (21):1386
    View PubMed
  82. Mattivi CL, Bos JM, Bagnall RD, Nowak N, Giudicessi JR, Ommen SR, Semsarian C, Ackerman MJ. Clinical Utility of a Phenotype-Enhanced MYH7-Specific Variant Classification Framework in Hypertrophic Cardiomyopathy Genetic Testing. Circ Genom Precis Med. 2020 Oct; 13 (5):453-459 Epub 2020 Sept 07
    View PubMed
  83. Stephens EH, Dearani JA, Johnson JN, Ackerman MJ, Ommen SR, Schaff HV. The Surgeon's View of the Left Ventricular Outflow Tract in Congenital Heart Surgery. World J Pediatr Congenit Heart Surg. 2020 Sep; 11 (5):595-610
    View PubMed
  84. Bos JM, Hebl VB, Oberg AL, Sun Z, Herman DS, Teekakirikul P, Seidman JG, Seidman CE, Dos Remedios CG, Maleszewski JJ, Schaff HV, Dearani JA, Noseworthy PA, Friedman PA, Ommen SR, Brozovich FV, Ackerman MJ. Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19. Mayo Clin Proc. 2020 Jul; 95 (7):1354-1368 Epub 2020 Apr 28
    View PubMed
  85. Smith JR, Layrisse V, Medina-Inojosa JR, Berg JD, Ommen SR, Olson TP. Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy. Eur J Prev Cardiol. 2020 Jul; 27 (10):1066-1073 Epub 2020 Jan 22
    View PubMed
  86. Wyatt KD, Finley A, Uribe R, Pallagi P, Willaert B, Ommen S, Yiannias J, Hellmich T. Patients' Experiences and Attitudes of Using a Secure Mobile Phone App for Medical Photography: Qualitative Survey Study. J Med Internet Res. 2020 May 12; 22(5):e14412.
    View PubMed
  87. Bonura ED, Bos JM, Abdelsalam MA, Araoz PA, Ommen SR, Ackerman MJ, Geske JB. Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age. Am J Cardiol. 2020 Apr 15; 125 (8):1249-1255 Epub 2020 Jan 28
    View PubMed
  88. Cui H, Schaff HV, Abel MD, Helder MRK, Frye RL, Ommen SR, Nishimura RA. Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis. J Thorac Cardiovasc Surg. 2020 Mar; 159 (3):844-852.e1 Epub 2019 Apr 04
    View PubMed
  89. Nguyen A, Schaff HV, Sedeek AF, Geske JB, Dearani JA, Ommen SR, Lahr BD, Viehman JK, Nishimura RA. Septal Myectomy and Concomitant Coronary Artery Bypass Grafting for Patients With Hypertrophic Cardiomyopathy and Coronary Artery Disease. Mayo Clin Proc. 2020 Mar; 95 (3):521-525
    View PubMed
  90. Geske JB, Driver CN, Yogeswaran V, Ommen SR, Schaff HV. Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy. Am Heart J. 2020 Mar; 221:159-164 Epub 2019 Dec 18
    View PubMed
  91. Ko WY, Siontis KC, Attia ZI, Carter RE, Kapa S, Ommen SR, Demuth SJ, Ackerman MJ, Gersh BJ, Arruda-Olson AM, Geske JB, Asirvatham SJ, Lopez-Jimenez F, Nishimura RA, Friedman PA, Noseworthy PA. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram. J Am Coll Cardiol. 2020 Feb 25; 75 (7):722-733
    View PubMed
  92. Nguyen A, Schaff HV, Nishimura RA, Geske JB, Dearani JA, King KS, Ommen SR. Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure. J Thorac Cardiovasc Surg. 2020 Jan; 159 (1):145-152 Epub 2019 Apr 05
    View PubMed
  93. Patel SI, Shamoun FE, Esser H, Parthasarathy S, Ackerman MJ, Geske JB, Ommen SR, Love WT, Somers VK, Chahal CA, Bos JM, Cha SS, Lester SJ. Sleep Disordered Breathing in Hypertrophic Cardiomyopathy Sleep and Vigilance. 2019; 4.1(4.1):3-9. Epub 2020 Jun 01.
  94. Choi YJ, Kim HK, Lee SC, Park JB, Moon I, Park J, Kim YJ, Sohn DW, Ommen S. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians. Heart. 2019 Dec; 105 (24):1892-1897 Epub 2019 Aug 05
    View PubMed
  95. Cullen MW, Geske JB, Anavekar NS, McAdams JA, Beliveau ME, Ommen SR, Nishimura RA. Reinvigorating Continuing Medical Education: Meeting the Challenges of the Digital Age. Mayo Clin Proc. 2019 Dec; 94 (12):2501-2509
    View PubMed
  96. Lee H, Han K, Park JB, Hwang IC, Yoon YE, Park HE, Choi SY, Kim YJ, Cho GY, Kim HK, Ommen SR. Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study. Sci Rep. 2019 Oct 10; 9 (1):14565
    View PubMed
  97. Zhou W, Bos JM, Ye D, Tester DJ, Hrstka S, Maleszewski JJ, Ommen SR, Nishimura RA, Schaff HV, Kim CS, Ackerman MJ. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations. J Cardiovasc Transl Res. 2019 Oct; 12 (5):394-403 Epub 2019 Feb 22
    View PubMed
  98. Nguyen A, Schaff HV, Nishimura RA, Geske JB, Ackerman MJ, Bos JM, Dearani JA, Ommen SR. Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality? Ann Thorac Surg. 2019 Sep; 108 (3):723-729 Epub 2019 Apr 09
    View PubMed
  99. Lee HJ, Kim HK, Jung JH, Han KD, Lee H, Park JB, Kim HM, Kim YJ, Ommen SR. Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation. Stroke. 2019 Sep; 50 (9):2582-2586 Epub 2019 July 25
    View PubMed
  100. Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2019 Aug 6; 74 (5):645-655
    View PubMed
  101. Moon S, Liu S, Scott CG, Samudrala S, Abidian MM, Geske JB, Noseworthy PA, Shellum JL, Chaudhry R, Ommen SR, Nishimura RA, Liu H, Arruda-Olson AM. Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing. Int J Med Inform. 2019 Aug; 128:32-38 Epub 2019 May 13
    View PubMed
  102. Ommen SR. Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: Wither Our Cognitive Miser. JAMA Cardiol 2019 Jul 1; 4 (7):657-658
    View PubMed
  103. Meghji Z, Nguyen A, Fatima B, Geske JB, Nishimura RA, Ommen SR, Lahr BD, Dearani JA, Schaff HV. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019 Mar 1; 4 (3):237-245
    View PubMed
  104. Hang D, Schaff HV, Nishimura RA, Lahr BD, Abel MD, Dearani JA, Ommen SR. Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2019 Mar; 32 (3):333-340 Epub 2018 Dec 28
    View PubMed
  105. Patel SI, Ackerman MJ, Shamoun FE, Geske JB, Ommen SR, Love WT, Cha SS, Bos JM, Lester SJ. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy. Acta Cardiol. 2019 Feb; 74 (1):53-58 Epub 2018 Mar 07
    View PubMed
  106. Holst KA, Hanson KT, Ommen SR, Nishimura RA, Habermann EB, Schaff HV. Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery. Mayo Clin Proc. 2019 Jan; 94 (1):66-73
    View PubMed
  107. Newman DB, Miranda WR, Matern D, Peck DS, Geske JB, Maleszewski JJ, Ommen SR, Ackerman MJ. Cost Efficacy of alpha-Galactosidase A Enzyme Screening for Fabry Disease. Mayo Clin Proc. 2019 Jan; 94 (1):84-88
    View PubMed
  108. Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort. J Thorac Cardiovasc Surg. 2019 Jan; 157 (1):306-315.e3 Epub 2018 Sept 05
    View PubMed
  109. Smith JR, Medina-Inojosa JR, Layrisse V, Ommen SR, Olson TP. Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy. J Clin Med. 2018 Nov 18; 7 (11)
    View PubMed
  110. Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR. Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy. Ann Thorac Surg. 2018 Aug; 106 (2):447-453 Epub 2018 Apr 19
    View PubMed
  111. Hang D, Schaff HV, Ommen SR, Dearani JA, Nishimura RA. Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2018 May; 155 (5):2096-2102 Epub 2017 Oct 27
    View PubMed
  112. Geske JB, Ommen SR, Gersh BJ. Hypertrophic Cardiomyopathy: Clinical Update. JACC Heart Fail. 2018 May; 6 (5):364-375 Epub 2018 Apr 11
    View PubMed
  113. Blackshear JL, Safford RE, Thomas CS, Bos JM, Ackerman MJ, Geske JB, Ommen SR, Shapiro BP, Johns GS. Platelet Function Analyzer 100 and Brain Natriuretic Peptide as Biomarkers in Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Mar 15; 121 (6):768-774 Epub 2017 Dec 25
    View PubMed
  114. O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM). Circulation. 2018 Mar 6; 137 (10):1015-1023 Epub 2017 Nov 30
    View PubMed
  115. Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? Eur J Cardiothorac Surg. 2018 Mar 1; 53 (3):582-589
    View PubMed
  116. Larsen CM, Ball CA, Hebl VB, Ong KC, Siontis KC, Olson TP, Ackerman MJ, Ommen SR, Allison TG, Geske JB. Effect of Body Mass Index on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Jan 1; 121 (1):100-106 Epub 2017 Oct 12
    View PubMed
  117. Padang R, Gersh BJ, Ommen SR, Geske JB. Prevalence and Impact of Coexistent Bicuspid Aortic Valve in Hypertrophic Cardiomyopathy. Heart Lung Circ. 2018 Jan; 27 (1):33-40 Epub 2017 Mar 08
    View PubMed
  118. Geske JB, Ong KC, Siontis KC, Hebl VB, Ackerman MJ, Hodge DO, Miller VM, Nishimura RA, Oh JK, Schaff HV, Gersh BJ, Ommen SR. Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J. 2017 Dec 7; 38 (46):3434-3440
    View PubMed
  119. Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Ommen SR. Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients With Hypertrophic Cardiomyopathy. Circulation 2017 Nov 14; 136 (20):1979-1981
    View PubMed
  120. Maron BJ, Dearani JA, Maron MS, Ommen SR, Rastegar H, Nishimura RA, Swistel DG, Sherrid MV, Ralph-Edwards A, Rakowski H, Smedira NG, Rowin EJ, Desai MY, Lever HM, Spirito P, Ferrazzi P, Schaff HV. Why we need more septal myectomy surgeons: An emerging recognition. J Thorac Cardiovasc Surg 2017 Nov; 154 (5):1681-1685 Epub 2017 Feb 01
    View PubMed
  121. Bois JP, Geske JB, Foley TA, Ommen SR, Pellikka PA. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Am J Cardiol. 2017 Feb 15; 119: (4)643-650.
    View PubMed
  122. Sugrue A, Killu AM, DeSimone CV, Chahal AA, Vogt JC, Kremen V, Hai J, Hodge DO, Acker NG, Geske JB, Ackerman MJ, Ommen SR, Lin G, Noseworthy PA, Brady PA. Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy. Open Heart. 2017; 4(1):e000561. Epub 2017 Feb 23.
  123. Prasad M, Geske JB, Sorajja P, Ommen SR, Schaff HV, Gersh BJ, Nishimura RA. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction. Catheter Cardiovasc Interv. 2016 Nov 15; 88 (6):962-970 Epub 2016 Apr 06
    View PubMed
  124. Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, Li Z, Ommen SR. Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures. J Am Coll Cardiol. 2016 Oct 4; 68 (14):1497-504
    View PubMed
  125. Ong KC, Geske JB, Hebl VB, Nishimura RA, Schaff HV, Ackerman MJ, Klarich KW, Siontis KC, Coutinho T, Dearani JA, Ommen SR, Gersh BJ. Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016 Jun; 17(6):604-10. Epub 2016 Feb 27.
    View PubMed
  126. Ommen SR, Nishimura RA. Hypertrophic Cardiomyopathy-One Case per Year?: A Clarion Call to Do What Is Right. JAMA Cardiol 2016 Jun 1; 1 (3):333-4
    View PubMed
  127. Murphy SL, Anderson JH, Kapplinger JD, Kruisselbrink TM, Gersh BJ, Ommen SR, Ackerman MJ, Bos JM. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy. J Cardiovasc Transl Res. 2016 Apr; 9 (2):153-61 Epub 2016 Feb 25
    View PubMed
  128. Hong J, Schaff HV, Ommen SR, Abel MD, Dearani JA, Nishimura RA. Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination. J Thorac Cardiovasc Surg. 2016 Apr; 151: (4)1044-8.
    View PubMed
  129. Bois JP, Adams JC, Kumar G, Ommen SR, Nishimura RA, Klarich KW. Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Mar 15; 117 (6):961-5 Epub 2015 Dec 31
    View PubMed
  130. Hebl VB, Miranda WR, Ong KC, Hodge DO, Bos JM, Gentile F, Klarich KW, Nishimura RA, Ackerman MJ, Gersh BJ, Ommen SR, Geske JB. The Natural History of Nonobstructive Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2016 Mar; 91 (3):279-87
    View PubMed
  131. Arscott P, Caleshu C, Kotzer K, Kreykes S, Kruisselbrink T, Orland K, Rigelsky C, Smith E, Spoonamore K, Larsen Haidle J, Marvin M, Ackerman MJ, Hadi A, Mani A, Ommen S, Cherny S. A Case for Inclusion of Genetic Counselors in Cardiac Care. Cardiol Rev. 2016 Mar-Apr; 24 (2):49-55
    View PubMed
  132. Adams JC, Bois JP, Masaki M, Yuasa T, Oh JK, Ommen SR, Nishimura RA, Klarich KW. Postprandial Hemodynamics in Hypertrophic Cardiomyopathy. Echocardiography. 2015 Nov; 32: (11)1614-20.
    View PubMed
  133. Loar RW, Bos JM, Will ML, Ommen SR, Ackerman MJ. Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults. Congenit Heart Dis. 2015 Nov-Dec; 10: (6)529-36.
    View PubMed
  134. Geske JB, Ommen SR. Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2015 Sep; 30: (5)493-9.
    View PubMed
  135. Ruzek L, Konecny T, Soucek F, Konecny D, Mach L, Ommen SR, Kopecky SL, Nishimura RA. Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Aug 15; 116(4):618-21. Epub 2015 May 21.
    View PubMed
  136. Kebed KY, Bos JM, Anavekar NS, Mulvagh SL, Ackerman MJ, Ommen SR. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression. Circ Cardiovasc Imaging. 2015 Jul; 8: (7)e003312.
    View PubMed
  137. Quintana E, Sabate-Rotes A, Maleszewski JJ, Ommen SR, Nishimura RA, Dearani JA, Schaff HV. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy? J Thorac Cardiovasc Surg. 2015 Jul; 150 (1):159-67.e1 Epub 2015 Mar 31
    View PubMed
  138. Konecny T, Geske JB, Ludka O, Orban M, Brady PA, Abudiab MM, Albuquerque FN, Placek A, Kara T, Sahakyan KR, Gersh BJ, Tajik AJ, Allison TG, Ommen SR, Somers VK. Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy. Chest. 2015 Jun; 147 (6):1574-1581
    View PubMed
  139. Quintana E, Johnson JN, Sabate Rotes A, Cetta F, Ommen SR, Schaff HV, Dearani JA. Surgery for biventricular obstruction in hypertrophic cardiomyopathy in children and young adults: technique and outcomesdagger. Eur J Cardiothorac Surg. 2015 Jun; 47: (6)1006-12.
    View PubMed
  140. Towe EC, Bos JM, Ommen SR, Gersh BJ, Ackerman MJ. Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy. Congenit Heart Dis. 2015 May-Jun; 10 (3):E139-45 Epub 2014 Dec 14
    View PubMed
  141. Cook DA, Sorensen KJ, Nishimura RA, Ommen SR, Lloyd FJ. A comprehensive information technology system to support physician learning at the point of care. Acad Med. 2015 Jan; 90(1):33-9.
    View PubMed
  142. Helder MR, Schaff HV, Nishimura RA, Gersh BJ, Dearani JA, Ommen SR, Mereuta OM, Theis JD, Dogan A, Edwards WD. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction. Am J Cardiol. 2014 Nov 1; 114 (9):1396-9 Epub 2014 Aug 12
    View PubMed
  143. Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, Ommen S. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. J Thorac Cardiovasc Surg. 2014 Sep; 148 (3):909-15; discussion 915-6 Epub 2014 May 16
    View PubMed
  144. Geske JB, Konecny T, Ommen SR, Nishimura RA, Sorajja P, Schaff HV, Ackerman MJ, Gersh BJ. Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2014 Aug 7; 35 (30):2032-9 Epub 2013 Dec 13
    View PubMed
  145. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014 Jul 8; 64 (1):83-99
    View PubMed
  146. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc. 2014 Jun 25; 3 (3):e001002 Epub 2014 June 25
    View PubMed
  147. Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2014 Jun; 89 (6):727-37 Epub 2014 May 01
    View PubMed
  148. Geske JB, Bos JM, Gersh BJ, Ommen SR, Eidem BW, Ackerman MJ. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2014 Apr; 15: (4)456-65.
    View PubMed
  149. Kebed KY, Al Adham RI, Bishu K, Askew JW, Klarich KW, Oh JK, Julsrud PR, Foley TA, Glockner JF, Nishimura RA, Ommen SR, Anavekar NS. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI. Int J Cardiovasc Imaging. 2014 Mar; 30 (3):591-7 Epub 2014 Jan 05
    View PubMed
  150. Sorajja P, Ommen SR, Nishimura RA. Symptomatic obstructive hypertrophic cardiomyopathy. Marine Ecology Progress Series. 2014; 495:131-42.
  151. Geske JB, Klarich KW, Ommen SR, Schaff HV, Nishimura RA. Septal reduction therapies in hypertrophic cardiomyopathy: Comparison of surgical septal myectomy and alcohol septal ablation. Interventional Cardiology (London). 2014; 6(2):199-215.
  152. Kunkala MR, Schaff HV, Burkhart H, Sandhu GS, Spoon DB, Ommen SR, Sorajja P, Dearani JA. Outcome of repair of myocardial bridging at the time of septal myectomy. Ann Thorac Surg. 2014 Jan; 97(1):118-23. Epub 2013 Sep 24
    View PubMed
  153. Sorajja P, Ommen SR, Nishimura RA. Symptomatic obstructive hypertrophic cardiomyopathy. Circ Cardiovasc Interv. 2013 Oct 1; 6(5):586-91.
    View PubMed
  154. Kunkala MR, Schaff HV, Nishimura RA, Abel MD, Sorajja P, Dearani JA, Ommen SR. Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. Ann Thorac Surg. 2013 Aug; 96(2):564-70. Epub 2013 Jun 26.
    View PubMed
  155. Geske JB, McKie PM, Ommen SR, Sorajja P. B-type natriuretic peptide and survival in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jun 18; 61 (24):2456-2460 Epub 2013 Apr 16
    View PubMed
  156. Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK, Ackerman MJ, Nishimura RA, Tajik AJ, Ommen SR. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2013 Jun 15; 111 (12):1784-91 Epub 2013 Mar 27
    View PubMed
  157. Said SM, Dearani JA, Ommen SR, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther. 2013 May; 11(5):617-27.
    View PubMed
  158. Steckelberg RC, Tseng AS, Nishimura R, Ommen S, Sorajja P. Derivation of mean pulmonary artery pressure from noninvasive parameters. J Am Soc Echocardiogr. 2013 May; 26 (5):464-8 Epub 2013 Feb 11
    View PubMed
  159. Wooten EC, Hebl VB, Wolf MJ, Greytak SR, Orr NM, Draper I, Calvino JE, Kapur NK, Maron MS, Kullo IJ, Ommen SR, Bos JM, Ackerman MJ, Huggins GS. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2013 Feb; 6(1):10-8. Epub 2012 Dec 19.
    View PubMed
  160. Orme NM, Sorajja P, Dearani JA, Schaff HV, Gersh BJ, Ommen SR. Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope. Am J Cardiol. 2013 Feb 1; 111(3):388-92. Epub 2012 Nov 17.
    View PubMed
  161. Altarabsheh SE, Dearani JA, Burkhart HM, Schaff HV, Deo SV, Eidem BW, Ommen SR, Li Z, Ackerman MJ. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. Ann Thorac Surg. 2013 Feb; 95(2):663-9; discussion 669. Epub 2012 Oct 04.
    View PubMed
  162. Konecny T, Nehra A, Pellikka PA, Ommen SR, Kopecky SL. Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction. Journal of Men's Health. 2013; 10(4):152-3.
  163. Kunkala MR, Aubry MC, Ommen SR, Gersh BJ, Schaff HV. Outcome of septal myectomy in patients with Fabry's disease. Ann Thorac Surg. 2013 Jan; 95: (1)335-7.
    View PubMed
  164. Sorajja P, Binder J, Nishimura RA, Holmes DR Jr, Rihal CS, Gersh BJ, Bresnahan JF, Ommen SR. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2013 Jan 1; 81 (1):E58-67 Epub 2012 Apr 17
    View PubMed
  165. Sorajja P, Ommen SR, Holmes DR Jr, Dearani JA, Rihal CS, Gersh BJ, Lennon RJ, Nishimura RA. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012 Nov 13; 126 (20):2374-80 Epub 2012 Oct 17
    View PubMed
  166. Geske JB, Cullen MW, Sorajja P, Ommen SR, Nishimura RA. Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis. JACC Cardiovasc Interv. 2012 Jun; 5 (6):675-81
    View PubMed
  167. Sorajja P, Allison T, Hayes C, Nishimura RA, Lam CS, Ommen SR. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2012 May 15; 109 (10):1494-8 Epub 2012 Feb 21
    View PubMed
  168. Purevjav E, Arimura T, Augustin S, Huby AC, Takagi K, Nunoda S, Kearney DL, Taylor MD, Terasaki F, Bos JM, Ommen SR, Shibata H, Takahashi M, Itoh-Satoh M, McKenna WJ, Murphy RT, Labeit S, Yamanaka Y, Machida N, Park JE, Alexander PM, Weintraub RG, Kitaura Y, Ackerman MJ, Kimura A, Towbin JA. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet. 2012 May 1; 21(9):2039-53. Epub 2012 Jan 27.
    View PubMed
  169. Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovasc Surg. 2012 Feb; 143(2):303-9. Epub 2011 Dec 10.
    View PubMed
  170. American College of Cardiology Foundation/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011 Dec; 142(6):e153-203.
    View PubMed
  171. Ommen SR. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 2011 Nov; 36(11):409-53.
    View PubMed
  172. Kansal MM, Lester SJ, Surapaneni P, Sengupta PP, Appleton CP, Ommen SR, Ressler SW, Hurst RT. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy. Am J Cardiol. 2011 Nov 1; 108(9):1322-6. Epub 2011 Aug 18.
    View PubMed
  173. Binder J, Attenhofer Jost CH, Klarich KW, Connolly HM, Tajik AJ, Scott CG, Julsrud PR, Ehrsam JE, Bailey KR, Ommen SR. Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr. 2011 Jul; 24 (7):775-81 Epub 2011 Apr 20
    View PubMed
  174. Ashikhmina EA, Schaff HV, Ommen SR, Dearani JA, Nishimura RA, Abel MD. Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011 Jul; 142(1):53-9. Epub 2010 Sep 29
    View PubMed
  175. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011 Jun; 4(6):704-9.
    View PubMed
  176. Borlaug BA, Jaber WA, Ommen SR, Lam CS, Redfield MM, Nishimura RA. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart. 2011 Jun; 97 (12):964-9 Epub 2011 Apr 08
    View PubMed
  177. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR, Woo A, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, Society of Cardiovascular Computed Tomography. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2011 May; 24(5):473-98.
    View PubMed
  178. Johnson JN, Grifoni C, Bos JM, Saber-Ayad M, Ommen SR, Nistri S, Cecchi F, Olivotto I, Ackerman MJ. Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J. 2011 May; 32 (9):1114-20 Epub 2011 Feb 22
    View PubMed
  179. Blackshear JL, Schaff HV, Ommen SR, Chen D, Nichols WL. Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy. Mayo Clin Proc. 2011 Mar; 86 (3):219-24
    View PubMed
  180. Desai MY, Ommen SR, McKenna WJ, Lever HM, Elliott PM. Imaging phenotype versus genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2011 Mar; 4(2):156-68.
    View PubMed
  181. Brown ML, Schaff HV, Dearani JA, Li Z, Nishimura RA, Ommen SR. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg. 2011 Feb; 141(2):439-43. Epub 2010 Sep 15.
    View PubMed
  182. Landstrom AP, Adekola BA, Bos JM, Ommen SR, Ackerman MJ. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing. Am Heart J. 2011 Jan; 161 (1):165-71
    View PubMed
  183. Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Nov 15; 106(10):1481-6.
    View PubMed
  184. Kapa S, Martinez MW, Williamson EE, Ommen SR, Syed IS, Feng D, Packer DL, Brady PA. ECG-gated dual-source CT for detection of left atrial appendage thrombus in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2010 Nov; 29(2):75-81. Epub 2010 Sep 1
    View PubMed
  185. Force T, Bonow RO, Houser SR, Solaro RJ, Hershberger RE, Adhikari B, Anderson ME, Boineau R, Byrne BJ, Cappola TP, Kalluri R, LeWinter MM, Maron MS, Molkentin JD, Ommen SR, Regnier M, Tang WH, Tian R, Konstam MA, Maron BJ, Seidman CE. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation. 2010 Sep 14; 122(11):1130-3.
    View PubMed
  186. Kumar G, Macdonald RJ, Sorajja P, Edwards WD, Ommen SR, Klarich KW. Papillary fibroelastomas in 19 patients with hypertrophic cardiomyopathy undergoing septal myectomy. J Am Soc Echocardiogr. 2010 Jun; 23: (6)595-8.
    View PubMed
  187. Konecny T, Brady PA, Orban M, Lin G, Pressman GS, Lehar F, Tomas K, Gersh BJ, Tajik AJ, Ommen SR, Somers VK. Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2010 Jun 1; 105(11):1597-602. Epub 2010 Apr 14.
    View PubMed
  188. Lam CS, Grewal J, Borlaug BA, Ommen SR, Kane GC, McCully RB, Pellikka PA. Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity. Hypertension. 2010 May; 55 (5):1143-9 Epub 2010 Mar 09
    View PubMed
  189. Adams JC, Ommen SR, Klarich KW, Tajik AJ, Nishimura RA. Significance of postprandial symptom exacerbation in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Apr 01; 105: (7)990-2.
    View PubMed
  190. Schaff HV, Brown ML, Dearani JA, Abel MD, Ommen SR, Sorajja P, Tajik AJ, Nishimura RA. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2010 Mar; 139(3):634-40.
    View PubMed
  191. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010 Jan; 3 (1):51-8 Epub 2009 Oct 22
    View PubMed
  192. Menon SC, Eidem BW, Dearani JA, Ommen SR, Ackerman MJ, Miller D. Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adolescents. J Am Soc Echocardiogr. 2009 Dec; 22 (12):1327-34 Epub 2009 Oct 07
    View PubMed
  193. Eleid MF, Konecny T, Orban M, Sengupta PP, Somers VK, Parish JM, Mookadam F, Brady PA, Sullivan BL, Khandheria BK, Ommen SR, Tajik AJ. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2009 Nov 3; 54 (19):1805-9
    View PubMed
  194. McLeod CJ, Bos JM, Theis JL, Edwards WD, Gersh BJ, Ommen SR, Ackerman MJ. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J. 2009 Nov; 158 (5):799-805 Epub 2009 Oct 03
    View PubMed
  195. Wan CK, Dearani JA, Sundt TM 3rd, Ommen SR, Schaff HV. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation? Ann Thorac Surg. 2009 Sep; 88: (3)727-31; discussion 731-2.
    View PubMed
  196. Blauwet LA, Ackerman MJ, Edwards WD, Riehle DL, Ommen SR. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system. Cardiovasc Pathol. 2009 Sep-Oct; 18: (5)262-8.
    View PubMed
  197. Geske JB, Sorajja P, Nishimura RA, Ommen SR. The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. J Am Soc Echocardiogr. 2009 Aug; 22: (8)961-6.
    View PubMed
  198. Nakajima Y, Kane GC, McCully RB, Ommen SR, Pellikka PA. Left ventricular diastolic filling pressures during dobutamine stress echocardiography: relationship to symptoms and ischemia. J Am Soc Echocardiogr. 2009 Aug; 22: (8)947-53.
    View PubMed
  199. McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol. 2009 Jul 14; 54(3):229-33.
    View PubMed
  200. Sorajja P, Nishimura RA, Gersh BJ, Dearani JA, Hodge DO, Wiste HJ, Ommen SR. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. J Am Coll Cardiol. 2009 Jul 14; 54(3):234-41.
    View PubMed
  201. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol. 2009 Jul; 32 (7):397-402
    View PubMed
  202. Theis JL, Bos JM, Theis JD, Miller DV, Dearani JA, Schaff HV, Gersh BJ, Ommen SR, Moss RL, Ackerman MJ. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. Circ Heart Fail. 2009 Jul; 2 (4):325-33 Epub 2009 May 13
    View PubMed
  203. Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart. 2009 May; 95(9):709-14. Epub 2009 Mar 11.
    View PubMed
  204. Park SM, Park SW, Casaclang-Verzosa G, Ommen SR, Pellikka PA, Miller FA, Sarano ME, Kubo SH, Oh JK. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. 2009 Apr; 157(4):762.e3-10.
    View PubMed
  205. Dearani JA, Schaff HV, Ommen SR. [Septal myectomy for obstructive hypertrophic cardiomyopathy: the gold standard]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr; 37(4):307-11.
    View PubMed
  206. Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ Cardiovasc Genet. 2009 Feb; 2(1):81-5; discussion 86.
    View PubMed
  207. Martinez MW, Kirsch J, Williamson EE, Syed IS, Feng D, Ommen S, Packer DL, Brady PA. Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation. JACC Cardiovasc Imaging. 2009 Jan; 2 (1):69-76
    View PubMed
  208. Sengupta PP, Sorajja D, Eleid MF, Somers VK, Ommen SR, Parish JM, Khandheria B, Tajik AJ. Hypertrophic obstructive cardiomyopathy and sleep-disordered breathing: an unfavorable combination. Nat Clin Pract Cardiovasc Med. 2009 Jan; 6 (1):14-5 Epub 2008 Nov 18
    View PubMed
  209. Ting HH, Ommen SR, Foley DA, Timimi FK, Hayes DL. Perfecting patient-centered care: the needs of the patient come first. J Cardiovasc Transl Res. 2008 Dec; 1 (4):295-300 Epub 2008 Oct 07
    View PubMed
  210. Kiernan TJ, Weivoda PL, Somers VK, Ommen SR, Gersh BJ. Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2008 Oct; 31(10):1253-8.
    View PubMed
  211. Park SJ, Miyazaki C, Bruce CJ, Ommen S, Miller FA, Oh JK. Left ventricular torsion by two-dimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction. J Am Soc Echocardiogr. 2008 Oct; 21: (10)1129-37.
    View PubMed
  212. Bunch TJ, Munger TM, Friedman PA, Asirvatham SJ, Brady PA, Cha YM, Rea RF, Shen WK, Powell BD, Ommen SR, Monahan KH, Haroldson JM, Packer DL. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008 Oct; 19 (10):1009-14 Epub 2008 May 09
    View PubMed
  213. Sorajja P, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Holmes DR Jr. Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study. JACC Cardiovasc Interv. 2008 Oct; 1(5):552-60.
    View PubMed
  214. Ommen SR, Shah PM, Tajik AJ. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Heart. 2008 Oct; 94(10):1276-81. Epub 2008 Jul 24.
    View PubMed
  215. Martinez MW, Sorajja P, Ommen SR. Mid-cavitary obstruction in hypertrophic cardiomyopathy. Heart. 2008 Oct; 94(10):1287.
    View PubMed
  216. Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ommen SR, Potter JD, Ackerman MJ. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol. 2008 Aug; 45 (2):281-8 Epub 2008 May 11
    View PubMed
  217. Vaglio JC Jr, Ommen SR, Nishimura RA, Tajik AJ, Gersh BJ. Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction. Am Heart J. 2008 Aug; 156: (2)342-7.
    View PubMed
  218. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR Jr. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008 Jul 8; 118 (2):131-9
    View PubMed
  219. Binder J, Ommen SR, Sorajja P, Nishimura RA, Tajik AJ. Clinical and echocardiographic variables fail to predict response to dual-chamber pacing for hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2008 Jul; 21(7):796-800. Epub 2008 Jan 28.
    View PubMed
  220. Bos JM, Theis JL, Tajik AJ, Gersh BJ, Ommen SR, Ackerman MJ. Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy. Am Heart J. 2008 Jun; 155 (6):1128-34 Epub 2008 Feb 21
    View PubMed
  221. Menon SC, Ackerman MJ, Ommen SR, Cabalka AK, Hagler DJ, O'Leary PW, Dearani JA, Cetta F, Eidem BW. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2008 Jun; 21: (6)684-8.
    View PubMed
  222. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2008 Jun; 83(6):630-8.
    View PubMed
  223. Syed IS, Ommen SR, Breen JF, Tajik AJ. Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2008 May; 1: (3)377-9.
    View PubMed
  224. Elesber A, Nishimura RA, Rihal CS, Ommen SR, Schaff HV, Holmes DR Jr. Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2008 Feb 15; 101(4):516-20. Epub 2007 Dec 20.
    View PubMed
  225. Monteiro PF, Ommen SR, Gersh BJ, Dearani JA, Schaff HV, Nishimura RA, Tajik AJ. Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling. Am J Cardiol. 2007 Dec 15; 100: (12)1776-8.
    View PubMed
  226. Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007 Dec 4; 116 (23):2702-8 Epub 2007 Nov 19
    View PubMed
  227. ElBardissi AW, Dearani JA, Nishimura RA, Ommen SR, Stulak JM, Schaff HV. Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy. Mayo Clin Proc. 2007 Dec; 82(12):1516-22.
    View PubMed
  228. McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2007 Nov; 28(21):2583-8. Epub 2007 May 04.
    View PubMed
  229. Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med. 2007 Sep; 4 (9):503-12
    View PubMed
  230. Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? J Am Coll Cardiol. 2007 Aug 28; 50(9):831-4. Epub 2007 Aug 13.
    View PubMed
  231. Binder J, Ommen SR, Chen HH, Ackerman MJ, Tajik AJ, Jaffe AS. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007 Aug 15; 100: (4)712-4.
    View PubMed
  232. Jaber WA, Nishimura RA, Ommen SR. Not all systolic velocities indicate obstruction in hypertrophic cardiomyopathy: a simultaneous Doppler catheterization study. J Am Soc Echocardiogr. 2007 Aug; 20(8):1009.e5-7. Epub 2007 Jun 06.
    View PubMed
  233. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposito G, Lepri F, Faul C, Mundel P, Lopez Siguero JP, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007 Aug; 39(8):1007-12. Epub 2007 Jul 01.
    View PubMed
  234. Landstrom AP, Weisleder N, Batalden KB, Bos JM, Tester DJ, Ommen SR, Wehrens XH, Claycomb WC, Ko JK, Hwang M, Pan Z, Ma J, Ackerman MJ. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol. 2007 Jun; 42 (6):1026-35 Epub 2007 Apr 18
    View PubMed
  235. Bos JM, Ommen SR, Ackerman MJ. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol. 2007 May; 22(3):193-9.
    View PubMed
  236. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation. 2007 Apr 17; 115 (15):1982-90 Epub 2007 Apr 02
    View PubMed
  237. Bunch TJ, Chandrasekaran K, Ehrsam JE, Hammill SC, Urban LH, Hodge DO, Ommen SR, Pellikka PA. Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. Am J Cardiol. 2007 Mar 15; 99: (6)835-8.
    View PubMed
  238. Gilman G, Nelson TA, Hansen WH, Khandheria BK, Ommen SR. Diastolic function: a sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function. J Am Soc Echocardiogr. 2007 Feb; 20: (2)199-209.
    View PubMed
  239. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Jan 23; 49(3):350-7. Epub 2007 Jan 04.
    View PubMed
  240. Theis JL, Bos JM, Bartleson VB, Will ML, Binder J, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2006 Dec 29; 351: (4)896-902.
    View PubMed
  241. Vasile VC, Edwards WD, Ommen SR, Ackerman MJ. Obstructive hypertrophic cardiomyopathy is associated with reduced expression of vinculin in the intercalated disc. Biochem Biophys Res Commun. 2006 Oct 20; 349 (2):709-15 Epub 2006 Aug 24
    View PubMed
  242. Vasile VC, Ommen SR, Edwards WD, Ackerman MJ. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2006 Jul 7; 345(3):998-1003. Epub 2006 May 04.
    View PubMed
  243. Sorajja P, Nishimura RA, Ommen SR, Ackerman MJ, Tajik AJ, Gersh BJ. Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. J Am Soc Echocardiogr. 2006 Jun; 19 (6):788-95
    View PubMed
  244. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab. 2006 May; 88 (1):78-85 Epub 2005 Dec 13
    View PubMed
  245. Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, Ackerman MJ. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc. 2006 Apr; 81 (4):459-67
    View PubMed
  246. Vasile VC, Will ML, Ommen SR, Edwards WD, Olson TM, Ackerman MJ. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab. 2006 Feb; 87 (2):169-74 Epub 2005 Oct 19
    View PubMed
  247. Sorajja P, Chareonthaitawee P, Ommen SR, Miller TD, Hodge DO, Gibbons RJ. Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy. Am Heart J. 2006 Feb; 151: (2)426-35.
    View PubMed
  248. Ommen SR. Review: Non-invasive assessment of hypertrophic cardiomyopathy. J Cardiovasc Ultrasound. 2006; 14(3):85-91.
  249. Gilman G, Hansen WH, Prasad A, Ommen SR. Increased mitral regurgitation during the valsalva maneuver in a patient with pheochromocytoma, uncontrolled hypertension, cardiac hypertrophy, and dynamic outflow tract obstruction. Echocardiography. 2006 Jan; 23 (1):53-5
    View PubMed
  250. Kjaergaard J, Johnson BD, Pellikka PA, Cha SS, Oh JK, Ommen SR. Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2005 Dec; 18: (12)1373-80.
    View PubMed
  251. Perkins MJ, Van Driest SL, Will ML, Gersh BJ, Ommen SR, Ackerman MJ. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J. 2005 Nov; 26(22):2457-62.
    View PubMed
  252. Minakata K, Dearani JA, Schaff HV, O'Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005 Sep; 80(3):851-6.
    View PubMed
  253. Gilman G, Ommen SR, Hansen WH, Higano ST. Doppler echocardiographic evaluation of pulmonary regurgitation facilitates the diagnosis of constrictive pericarditis. J Am Soc Echocardiogr. 2005 Sep; 18: (9)892-5.
    View PubMed
  254. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 2; 46 (3):470-6
    View PubMed
  255. Van Driest SL, Gakh O, Ommen SR, Isaya G, Ackerman MJ. Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. Mol Genet Metab. 2005 Aug; 85 (4):280-5
    View PubMed
  256. McCully RB, Ommen SR, Klarich KW, Burger KN, Mahoney DW, Pellikka PA. Prognosis of patients with good exercise capacity and mildly abnormal exercise echocardiography results: identification of an at-risk subgroup. J Am Soc Echocardiogr. 2005 Jun; 18: (6)644-8.
    View PubMed
  257. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005 Jun; 80 (6):739-44
    View PubMed
  258. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005 Apr; 80(4):463-9.
    View PubMed
  259. Ha JW, Oh JK, Pellikka PA, Ommen SR, Stussy VL, Bailey KR, Seward JB, Tajik AJ. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. J Am Soc Echocardiogr. 2005 Jan; 18 (1):63-8
    View PubMed
  260. Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004 Dec 21; 44(12):2329-32.
    View PubMed
  261. Deb SJ, Schaff HV, Dearani JA, Nishimura RA, Ommen SR. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2004 Dec; 78: (6)2118-22.
    View PubMed
  262. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004 Nov 16; 44(10):2044-53.
    View PubMed
  263. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004 Nov 2; 44 (9):1903-10
    View PubMed
  264. Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ, Ackerman MJ. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004 Aug 4; 44 (3):602-10
    View PubMed
  265. Ha JW, Ommen SR, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh JK. Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol. 2004 Aug 1; 94 (3):316-9
    View PubMed
  266. Bergeron S, Ommen SR, Bailey KR, Oh JK, McCully RB, Pellikka PA. Exercise echocardiographic findings and outcome of patients referred for evaluation of dyspnea. J Am Coll Cardiol. 2004 Jun 16; 43(12):2242-6.
    View PubMed
  267. McCully RB, Roger VL, Ommen SR, Mahoney DW, Burger KN, Freeman WK, Pellikka PA. Outcomes of patients with reduced exercise capacity at time of exercise echocardiography. Mayo Clin Proc. 2004 Jun; 79: (6)750-7.
    View PubMed
  268. Ommen SR, Nishimura RA. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 2004 May; 29 (5):239-91
    View PubMed
  269. Hillis GS, Moller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004 Feb 4; 43 (3):360-7
    View PubMed
  270. Izhevsky D, Maple JT, Ommen SR. Acute myocardial infarction: an unusual culmination of rheumatic pancarditis and antiphospholipid antibody syndrome. J Intern Med. 2004 Feb; 255 (2):296-8
    View PubMed
  271. Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003 Nov 11; 108 (19):2342-8 Epub 2003 Oct 27
    View PubMed
  272. Nishimura RA, Ommen SR, Tajik AJ. Hypertrophic cardiomyopathy - A patient perspective. Circulation. 2003 Nov 11; 108(19):E133-5.
    View PubMed
  273. Ommen SR, Nishimura RA. A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart. 2003 Nov; 89 Suppl 3:iii18-23
    View PubMed
  274. Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Tajik AJ, Holmes DR, Holmes DR. Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003 Sep 3; 42 (5):889-94
    View PubMed
  275. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation. 2003 Jul 29; 108 (4):445-51 Epub 2003 July 14
    View PubMed
  276. Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA, Ommen SR, Jia G, Topol EJ. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol. 2003 Jul 15; 92(2):136-40.
    View PubMed
  277. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, Gersh BJ. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation. 2002 Dec 10; 106 (24):3085-90
    View PubMed
  278. Ha JW, Oh JK, Ommen SR, Ling LH, Tajik AJ. Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity. J Am Soc Echocardiogr. 2002 Dec; 15: (12)1468-71.
    View PubMed
  279. Ommen SR, Park SH, Click RL, Freeman WK, Schaff HV, Tajik AJ. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol. 2002 Nov 1; 90 (9):1022-4
    View PubMed
  280. Ommen SR, Hammill SC, Gibbons RJ. The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. Pacing & Clinical Electrophysiology. 2002 Oct; 25(10):1424-8.
    View PubMed
  281. Ackerman MJ, VanDriest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ, Gersh BJ. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy - A comprehensive outpatient perspective. J Am Coll Cardiol. 2002 Jun 19; 39(12):2042-8.
    View PubMed
  282. Ommen SR, Thomson HL, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Clinical predictors and consequences of atrial fibrillation after surgical myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2002 Jan 15; 89 (2):242-4
    View PubMed
  283. Yip GW, Ommen SR. Review article: Tissue Doppler imaging in coronary artery disease. Heart Views. 2002; 3(1):6-20.
  284. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Nov 15; 38 (6):1701-6
    View PubMed
  285. Ommen SR. Echocardiographic assessment of diastolic function. Curr Opin Cardiol. 2001 Jul; 16 (4):240-5
    View PubMed
  286. Ommen SR, Tsang TS, Ammash NM, Mahoney DW, Seward JB. Usefulness of serial echocardiographic parameters for predicting the subsequent occurrence of atrial fibrillation. Am J Cardiol. 2001 Jun 1; 87 (11):1298-301
    View PubMed
  287. Ommen SR, Nishimura RA. Hypertrophic cardiomyopathy: echocardiographic basis of therapy. ACC Current Journal Review. 2001; 10(1):46-49.
  288. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation. 2000 Oct 10; 102 (15):1788-94
    View PubMed
  289. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol. 2000 Jul 1; 86 (1):110-3
    View PubMed
  290. Ommen SR, Nishimura RA, Hurrell DG, Klarich KW. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc. 2000 Jan; 75 (1):24-9
    View PubMed
  291. Ommen SR, Nishimura RA. Review article: Treatment of patients with hypertrophic cardiomyopathy: A clinician's guide - 2001. Heart Views. 2000; 1(10):393-401.
  292. Haley JH, Sinak LJ, Tajik AJ, Ommen SR, Oh JK. Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: an important cause of new systolic murmur and cardiogenic shock. Mayo Clin Proc. 1999 Sep; 74: (9)901-6.
    View PubMed
  293. Ommen SR, Nishimura RA, Grill DE, Holmes DR Jr, Holmes DR Jr, Rihal CS. Comparison of long-term results of percutaneous mitral balloon valvotomy with closed transventricular mitral commissurotomy at a single North American Institution. Am J Cardiol. 1999 Sep 1; 84 (5):575-7
    View PubMed
  294. Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol. 1999 Jul; 34 (1):191-6
    View PubMed
  295. Ommen SR, Higano ST, Nishimura RA, Holmes DR Jr, Holmes DR. Summary of the Mayo Clinic experience with direct left ventricular puncture. Cathet Cardiovasc Diagn. 1998 Jun; 44 (2):175-8
    View PubMed
  296. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998 Jan 6-13; 97 (1):19-22
    View PubMed
  297. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997 May 15; 336 (20):1429-34
    View PubMed
  298. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997 Mar 15; 79 (6):812-4
    View PubMed
  299. Ommen SR, Hammill SC, Bailey KR. Failure of signal-averaged electrocardiography with use of time-domain variables to predict inducible ventricular tachycardia in patients with conduction defects. Mayo Clin Proc. 1995 Feb; 70 (2):132-6
    View PubMed
PST-20220392